Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Bergen, Norway, 15 February 2023 – Cytovation ASA, a clinical stage immune-oncology company focused on the development of CyPep-1, its first-in-class targeted tumor membrane immunotherapy, announces...
-
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Rom-coms, Hallmark movies and even Valentine's cards may need a rewrite: Most single people say they don't need a mate for their life story to have a...
-
Paris, 13 février 2023 – Ipsos a le plaisir d'annoncer l'acquisition d’Xperiti, une start-up spécialisée dans les études Business-to-Business (B2B), présente aux États-Unis, en Israël et aux...
-
Paris, February 13th, 2023 – Ipsos is pleased to announce the acquisition of Xperiti, a start-up specializing in Business-to-Business (B2B) research, with operations across the US, Israel and the...
-
BRUSSELS, Belgium, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The Eclipse Foundation, the EU’s largest open source software foundation, today announced it has secured three new research programs under the...
-
SAN FRANCISCO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Oomnitza, the leading provider of Enterprise Technology Management (ETM) solutions, today announced a new survey, the 2023 Snapshot Survey: SaaS and...
-
BOSTON, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Global 1000 companies are pulling back on longer-term innovation projects and allocating more resources toward the near term, according to the new research...
-
PORTOLA VALLEY, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of a laboratory study published in...
-
Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development
TORONTO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research...
-
TORONTO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...